TRIM72 and myeloid sarcoma: Our findings indicate that circulating levels of MG53 do not differ significantly between individuals diagnosed with MS and healthy controls and provide clinical evidence suggesting an absence of association between MG53 and MS parameters in the particular ethnic group studied.